- About the Center
- Research Programs
- Addiction Genetics and Pharmacogenetics Division
- Addiction Treatment and Medication Development Division
- Brain-Behavioral Vulnerabilities Laboratory
- HIV/AIDS Prevention Research Division
- Clinical Trials Network
- Novel Interventions in Criminal Justice Populations Division
- Continuing Care and Assessment Division
- Integrated Care for Primary Care
- Clinical Trial Participation
- Treatment Options
- Affiliated Divisions
- Center Faculty
- Post Doctoral Fellowships
- Recorded Seminars
- Public Education and Policy Work
- Contact Us
- Support Our Work
Reagan Wetherill, PhD, LCP
Additional Information & Contact: Dept. of Psychiatry link
Wetherill RR, Jagannathan K, Hager N, Maron M, Franklin TR. Influence of menstrual cycle phase on resting-state functional connectivity in naturally cycling, cigarette dependent women. Biol Sex Differ. 7:24, 2016.
Wetherill RR, Fromme K. Alcohol-induced blackouts: a review of recent clinical research with practical implications and recommendations for future studies. Alcohol Clin Exp Res. 40(5):922-935, 2016.
Wetherill RR, Jagannathan K, Hager N, Childress AR, Franklin TR. Sex differences in associations between cannabis craving and neural responses to cannabis cues: implications for treatment. Exp Clin Psychopharmacol. 23(4):238-246, 2015.
Grants & Funding
- K23 AA023894 – Effectiveness of topiramate: characterizing individual differences.
PNC Charitable Trusts - Hormones, the brain, and behavior: examining the causes and effects of alcohol use and relapse in women
Reagan R. Wetherill, PhD, LCP, is a Research Assistant Professor of Psychology in Psychiatry at the Perelman School of Medicine at the University of Pennsylvania and a licensed clinical psychologist. She received her PhD in Clinical Psychology from the University of Texas at Austin and completed her predoctoral internship/postdoctoral fellowship at the University of California, San Diego/VA San Diego Healthcare System. Her research focuses on the neurobiological substrates of alcohol and substance use disorders, pharmacogenetics, and sex differences/influence of hormones.
Back to Top